Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation

Cited by (1,000)

Items 401–500 of 1,000

1. Temporal Trends in Patient Risk Profile and Clinical Outcomes Following Percutaneous Coronary Intervention
   Luke P. Dawson, Diem Dinh, Stephen James Duffy, David Clark, Christopher Michael Reid, Angela Brennan, Nick Andrianopoulos, Chin Hiew, Melanie Freeman, Ernesto Oqueli et al. · 2020 · Cardiovascular revascularization medicine
2. Relevance of High Bleeding Risk and Postdischarge Bleeding in Patients Undergoing Percutaneous Coronary Intervention
   Brenden S. Ingraham, Marco Valgimigli, Dominick Joseph Angiolillo, Davide Capodanno, Sunil V. Rao, Philip M. Urban, Mandeep Singh · 2025 · Mayo Clinic Proceedings
3. Comparative Analysis of the Net Clinical Benefit of Direct Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Network Meta-analysis of Randomised Controlled Trials
   Ton Duy Mai, Tri Huynh Quang Ho, Sy Van Hoang, Hoai Thi Thu Nguyen, Jeyaraj Durai Pandian, Tan Van Nguyen, Khoa Tien Vu, Giang Song Tran, Viet Phương Đào, Minh C. Tran et al. · 2025 · European Cardiology Review
4. Bleeding Risk With Combining Antiplatelets and Anticoagulants for Secondary Stroke Prevention: A Propensity Score–Matched Analysis
   Salia Farrokh, Krishna Nalleballe, Sanjeeva Reddy Onteddu, Jose I. Suarez, Julian Bösel, Vishank Arun Shah · 2025 · Journal of the American Heart Association
5. Eurasian clinical guidelines for the diagnosis and treatment of atrial fibrillation in adult patients (2025)
   Golitsyn Sp, Е. П. Панченко, Nikolay Yu. Mironov, Беляева Мария Михайловна, D. A. Gagloeva, Eugenia M. Elfimova, Кропачева Екатерина Станиславовна, Lada Iu. Laiovich, Aleksander Yu. Litvin, E. B. Maykov et al. · 2025 · Eurasian heart journal
6. Antithrombotic Therapy in the Elderly with Cardiovascular Disease: Walking the Tightrope Between Efficacy and Bleeding Risk—A Narrative Review
   Alessandro Sciahbasi, Simona Minardi, Nicolò Salvi, Fabio Infusino, Antonino Granatelli · 2025 · Journal of Clinical Medicine
7. Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis
   Antonia Sambola, Pau Rello, Toni Soriano-Colomé, Deepak L. Bhatt, Vinay Pasupuleti, Christopher Paul Cannon, Charles Michael Gibson, Willem J.M. Dewilde, Gregory Y.H. Lip, Eric David Peterson et al. · 2020 · Thrombosis Research
8. Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
   Wenbin Lu, Yu Wang, Lijuan Chen, Yongjun Li, Rui Zhang, Zhongpu Chen, Jinchuan Yan, Mingming Yang, Bing Han, Zhirong Wang et al. · 2021 · Frontiers in Cardiovascular Medicine
9. 2019 Chinese expert consensus statement on left atrial appendage closure in patients with atrial fibrillation
   Ben He, Changsheng Ma, Shulin Wu · 2022 · Pacing and Clinical Electrophysiology
10. Management of combined oral antithrombotic therapy by an antithrombotic stewardship program: A prospective study
    Zhu Xian Zhang, Jutta M. Schroeder‐Tanka, Wim Stooker, Sanne van Wissen, Nakisa Khorsand · 2022 · British Journal of Clinical Pharmacology
11. Association of Concomitant Coronary Artery Disease With Cardiovascular Events in Patients With Atrial Fibrillation ― The Fushimi AF Registry ―
    Nobutoyo Masunaga, Hisashi Ogawa, Kimihito Minami, Kenjiro Ishigami, Syuhei Ikeda, Kosuke Doi, Yasuhiro Hamatani, Takashi Yoshizawa, Yuya Ide, Akiko Fujino et al. · 2022 · Circulation Journal
12. High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel
    René M’Pembele, Samantha Ahlbrecht, Carolin Helten, Philipp Mourikis, David Naguib, Saif Zako, Kajetan Trojovsky, Ragnar Huhn, Tobias Petzold, Thomas Hohlfeld et al. · 2022 · Pharmacology
13. Algorithm for the management of antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: an updated proposal based on efficacy considerations
    Andrea Rubboli, Gregory Y.H. Lip · 2020 · European Heart Journal - Cardiovascular Pharmacotherapy
14. Kommentar zu den Leitlinien (2019) der ESC zum chronischen Koronarsyndrom
    Helge Möllmann, David M. Leistner, Paul Christian Schulze, Udo P Sechtem, Johann K Bauersachs · 2020 · Der Kardiologe
15. Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age Trial
    Marieke E. Gimbel, Anne H. Tavenier, Willem L. Bor, Renicus Suffridus Hermanides, Evelyn A. de Vrey, Ton A.C.M. Heestermans, Melvyn Tjon Joe Gin, Reinier A. Waalewijn, Sjoerd H. Hofma, Frank den Hartog et al. · 2020 · Journal of Clinical Medicine
16. Antithrombotic Therapy With or Without Aspirin After Percutaneous Coronary Intervention or Acute Coronary Syndrome in Patients Taking Oral Anticoagulation: A Meta-Analysis and Network Analysis of Randomized Controlled Trials
    Róisín Colleran, Robert A. Byrne, Gjin Ndrepepa, Hector A. Alvarez‐Covarrubias, Katharina Mayer, Constantin Kuna, Himanshu Rai, Adnan Kastrati, Salvatore Cassese · 2021 · Cardiovascular revascularization medicine
17. Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention
    Si‐qi Lyu, Jun Zhu, Juan Wang, Shuang Wu, Han Zhang, Xing‐hui Shao, Yanmin Yang · 2021 · Thrombosis Research
18. Safety and efficacy of different anticoagulation regimens after left atrial appendage occlusion
    Wei Li, Runfeng Gao, Juan Zhao, Yin Ren, Gecai Chen, Jun‐guo Zhu, Kai Jin, Li Zhu, Zhongbao Ruan · 2022 · Annals of Palliative Medicine
19. Use of Anticoagulant Therapy in Patients with Acute Myocardial Infarction and Atrial Fibrillation
    Ratko Lasica, Lazar Djukanovic, Dejana Popović, Lidija Savić, Igor Mrdović, Nebojša Radovanović, Mina Radovanović, Marija M. Polovina, Radan Stojanović, Dragan Matić et al. · 2022 · Medicina
20. Evolving Antithrombotic Treatment Patterns for Patients With Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome or Underwent Percutaneous Coronary Intervention in China: A Cross-Sectional Study
    Ni Suo, Yanmin Yang, Juan Wang, Han Zhang, Xing‐hui Shao, Shuang Wu, Jun Zhu · 2022 · Frontiers in Cardiovascular Medicine
21. Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
    Willem L. Bor, Diana Adrienne Gorog · 2020 · Journal of Clinical Medicine
22. Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
    Andreas Schäfer, Ulrike Flierl, Johann K Bauersachs · 2020 · Clinical Research in Cardiology
23. The role of CHA2DS2-VASc score in evaluating patients with atrial fibrillation undergoing percutaneous coronary intervention
    Shane Parfrey, Andrew W. Teh, L. Roberts, Angela Brennan, David Clark, Stephen James Duffy, Andrew Edward Ajani, Christopher Michael Reid, Melanie Freeman · 2020 · Coronary Artery Disease
24. Primary percutaneous coronary intervention in nonagenarians: is it worthwhile?
    Mohammed N. Meah, Tobin Joseph, Wern Yew Ding, Matthew Shaw, Jonathan M Hasleton, Nick D. Palmer, Periaswamy Velavan, Suneil Kumar Aggarwal · 2021 · BMC Cardiovascular Disorders
25. Current Perspectives on Antithrombotic Therapy for the Treatment of Acute Coronary Syndrome
    Korakoth Towashiraporn, Rungroj Krittayaphong · 2022 · International Journal of General Medicine
26. Optimal antithrombotic strategy in patients with atrial fibrillation beyond 1 year after drug-eluting stent implantation: Design and rationale of the randomized ADAPT AF-DES trial
    Sang‐Hyup Lee, Seung‐Jun Lee, Jung Ho Heo, Sung Gyun Ahn, Joon-Hyoung Doh, Sanghoon Shin, Jaemin Shim, Ae‐Young Her, Byung Gyu Kim, Sang Wook Lim et al. · 2024 · American Heart Journal
27. Hemorrhage induced by antithrombotic agents: new insights from a real-world pharmacovigilance study
    Kangyuan Guo, Ganyi Wang, Li Zhang, Zhanchun Feng, Xudong Xia, Xiaobo Sun, Ziqi Yan, Zhiming Jiao, Da Feng · 2024 · Expert Opinion on Drug Safety
28. Percutaneous Coronary Intervention in Frail Patients Undergoing Transcatheter Aortic Valve Replacement
    Hanna Ratcovich, Lene Holmvang, Golnaz Sadjadieh, Reza Jabbari, Charlotte Glinge, Muhammad Sabbah, Karsten Tange Veien, Matti J. Niemelä, Phillip Freeman, Rickard Linder et al. · 2026 · JACC: Cardiovascular Interventions
29. Antiplatelet therapy for coronary artery disease in 2023: current status and future prospects
    Rishi Chandiramani, Alessandro Spirito, James Wheeler Johnson, Adhya Mehta, Birgit Vogel, Robert T. FAILLACE, Roxana Mehran · 2023 · Expert Review of Cardiovascular Therapy
30. Predicting new onset atrial fibrillation post acute myocardial infarction: Echocardiographic assessment of left atrial size
    Daniel V. Lancini, Aveechal Prasad, Liza Thomas, John James Atherton, Paul T. Martin, Sandhir B. Prasad · 2023 · Echocardiography
31. Selection of Non-vitamin K Antagonist Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation Based on Patient Profile: Perspectives from Vietnamese Experts. Part 2
    Minh That Ton, Tri Huynh Quang Ho, Viet Lan Nguyen, Hung Manh Pham, Sy Van Hoang, Nhan Thanh Vo, Thai Quoc Nguyen, Linh Tran Pham, Ton Duy Mai, Thang Huy Nguyen · 2023 · European Cardiology Review
32. Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study
    Hyo‐Jeong Ahn, So‐Ryoung Lee, JungMin Choi, Kyung‐Yeon Lee, Soonil Kwon, Eue‐Keun Choi, Seil Oh, Gregory Y.H. Lip · 2024 · EP Europace
33. Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R study
    Ying Xuan Gue, Vassilios Memtsas, Rahim Kanji, David M. Wellsted, Amanda D. Busby, Megan Smith, Enric Vilar, Alisdair Ryding, Deepa J. Arachchillage, Diana Adrienne Gorog · 2024 · Thrombosis Research
34. Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation
    Chinese Society of Cardiology, Chinese Medical Association, Heart Rhythm Committee of Chinese Society of Biomedical Engineering · 2024 · Cardiology Discovery
35. Antithrombotic Therapy for Acute Coronary Syndrome
    Toshiaki Toyota, Hirotoshi Watanabe, Kitae Kim, Yutaka Furukawa, Takeshi Kimura · 2025 · Journal of Neuroendovascular Therapy
36. A prospective interventional registry of short-term dual-antiplatelet treatment after implantation of drug-eluting stents in patients with atrial fibrillation requiring oral anticoagulation therapy
    Kazunori Horie, Takashi Matsumoto, Yukiko Mizutani, Norio Tada, Norichika Osai, Tsuyoshi Isawa, Masataka Taguri, Shigeaki Kato, Taku Honda, Tatsushi Ootomo et al. · 2019 · Cardiovascular Intervention and Therapeutics
37. Long-Term Incidence and Details of Bleeding Events After Everolimus-Eluting Stent Implantation ― 7–8-Year Outcomes ―
    Katsuya Miura, Takenobu Shimada, Masanobu Ohya, Ryosuke Murai, Hidewo Amano, Shunsuke Kubo, Takeshi Tada, Hiroyuki Tanaka, Yasushi Fuku, Tsuyoshi Goto et al. · 2019 · Circulation Journal
38. Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach?
    Natale Daniele Brunetti, Lucia Tricarico, Luisa De Gennaro, Michele Correale, Francesco Santoro, Riccardo Ieva, Massimo Iacoviello, Matteo Di Biase · 2020 · IJC Heart & Vasculature
39. Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation
    Iwona Gorczyca−Michta, Olga Elżbieta Jelonek, Anna Michalska, Magdalena Chrapek, Paweł Wałek, Beata Wożakowska−Kapłon · 2020 · Medicine
40. Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis
    Marco Vitolo, Saad Javed, Davide Capodanno, Andrea Rubboli, Giuseppe Boriani, Gregory Y.H. Lip · 2020 · Expert Review of Cardiovascular Therapy
41. Trends of Antithrombotic Treatment in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights from the GReek-AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry
    Despoina-Rafailia Benetou, Charalampos Varlamos, Dionysios Ktenas, Ioannis N. Tsiafoutis, Michael Koutouzis, Theodora Bampali, Christos Mantis, John Zarifis, Emmanouil I. Skalidis, D. Aravantinos et al. · 2020 · Cardiovascular Drugs and Therapy
42. Direct Oral Anticoagulants Combined with Antiplatelet Therapy in the Treatment of Coronary Heart Disease: An Updated Meta-analysis
    Leiling Liu, Hao Chuan Lei, Jiahui Hu, Ying Tang, Danyan Xu · 2021 · Drugs
43. Comparison of Bleeding Rates between Oral Anticoagulants in Combination with Dual Antiplatelet Therapy (Triple Therapy) in a Real-World Cohort
    Maya R. Chilbert, Sarah E. Reidy, Collin M. Clark, Marissa Guszkowski, Emma Gargala, Ashley E. Woodruff · 2021 · Hospital Pharmacy
44. Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
    Maarten J.G. Leening, Karim D. Mahmoud · 2021 · European Journal of Epidemiology
45. Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
    Leonardo De Luca, Raffaella Mistrulli, Francesco Antonio Veneziano, Francesco Grigioni, Massimo Volpe, Francesco Musumeci, Domenico Gabrielli · 2022 · Journal of Clinical Medicine
46. Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Bo Liang, Yong-Chun Zhu, Ning Gu · 2022 · Frontiers in Cardiovascular Medicine
47. P2Y12 Antagonists in Cardiovascular Disease—Finding the Best Balance Between Preventing Ischemic Events and Causing Bleeding
    Himawan Fernando, James D. McFadyen, Xiaowei Wang, James A. Shaw, Dion A. Stub, Karlheinz Peter · 2022 · Frontiers in Cardiovascular Medicine
48. Antithrombotic therapy after angioplasty of pulmonary vein stenosis due to atrial fibrillation ablation: A two‐center experience and review of the literature
    Thomas Fink, Julia Vogler, Riccardo Proietti, Vanessa Sciacca, Christian-Hendrik H. Heeger, Laura Rottner, Tilman Maurer, Andreas Metzner, Shibu Mathew, Charlotte Eitel et al. · 2022 · Journal of Arrhythmia
49. Non-major bleeding risk of direct oral anticoagulants versus vitamin K antagonists for stroke prevention with atrial fibrillation: a systematic review and network meta-analysis
    Fuxin Ma, Wenlin Xu, Jiana Chen, Jinhua Zhang · 2023 · European Journal of Clinical Pharmacology
50. Expanding Indications of Nonvitamin K Oral Anticoagulants Beyond Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Review of Emerging Clinical Evidence
    Adrija Hajra, Aditi Ujjawal, Natasha Ghalib, Selia Chowdhury, Suman Biswas, Prasanth Balasubramanian, Rahul Gupta, Wilbert S. Aronow · 2023 · Current Problems in Cardiology
51. Direct Oral Anticoagulants: An Overview of Indications, Pharmacokinetics, Comorbidities, and Perioperative Management
    Errol Moras, Kruti Gandhi, Mohammad Khan, Adlyn Moras, James Choi, William H. Frishman, Wilbert S. Aronow · 2023 · Cardiology in Review
52. Randomized Trial of COBRA PzF Stenting to Reduce the Duration of Triple Therapy: The COBRA-REDUCE Trial
    Robert A. Byrne, Róisín Colleran, John Joseph Coughlan, Rajiv Jauhar, Luc Maillard, Axel de Labriolle, Michael Mæng, Charles Croft, Michael P. Brunner, David M. Leistner et al. · 2024 · Circulation Cardiovascular Interventions
53. Efficacy and safety of single vs dual antiplatelet therapy in patients on anticoagulation undergoing percutaneous coronary intervention: A systematic review and meta‐analysis
    Varunsiri Atti, Mohit K. Turagam, Jalaj Garg, Poonam Velagapudi, Nileshkumar Patel, Mir B. Basir, Mark Terence P. Mujer, Supratik Rayamajhi, George S. Abela, Scott M Koerber et al. · 2019 · Journal of Cardiovascular Electrophysiology
54. The continuous challenge of antithrombotic strategies in diabetes: focus on direct oral anticoagulants
    Fulvio Pomero, Francesco Dentali, Nicola Mumoli, Pietro Salomone, Flavio Tangianu, Giovambattista Desideri, Daniela Mastroiacovo · 2019 · Acta Diabetologica
55. Real-World Antithrombotic Therapy in Atrial Fibrillation Patients with a History of Percutaneous Coronary Intervention
    Ai Horiguchi, Hidehira Fukaya, Jun Oikawa, Yuki Shirakawa, Shuhei Kobayashi, Yuki Arakawa, Ryo Nishinarita, Hironori K. Nakamura, Naruya Ishizue, Gen Igarashi et al. · 2019 · International Heart Journal
56. Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
    Tamara García Camarero, José M. de la Torre Hernández · 2020 · European Cardiology Review
57. Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
    Monika Kozieł, Tatjana Potpara, Gregory Y.H. Lip · 2020 · Research and Practice in Thrombosis and Haemostasis
58. Evaluation and optimization of prescribed concomitant antiplatelet and anticoagulation therapy centrally managed by an anticoagulation management service
    Sara A. Zekery-Saad, Andrea R. Lewin, Magie Pham, Katelyn Woods Sylvester, John R. Fanikos, Samuel Zachary Goldhaber, Jean M. Connors · 2020 · Journal of Thrombosis and Thrombolysis
59. Real-World Anticoagulatory Treatment After Transcatheter Aortic Valve Replacement: A Retrospective, Observational Study on 4,800 Patients
    Christopher Hohmann, Marion Ludwig, Jochen Walker, Hendrik Wienemann, Stephan Ernst Baldus, Roman Pfister · 2021 · Frontiers in Cardiovascular Medicine
60. Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation
    Keun‐Sik Hong · 2019 · Journal of Stroke
61. Using non-vitamin K oral anticoagulants in specific patient populations: a study of Korean cases
    IlYoung Cho - · 2019 · Therapeutics and Clinical Risk Management
62. Anticoagulation in patients with atrial fibrillation and coronary artery disease
    Fahad Alkindi, Ihsan M. Rafie · 2020 · Heart Views
63. Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues
    Monica Verdoia, Cyril Camaro, Elvin Kedhi, Marco Marcolongo, Harry Suryapranata, Giuseppe De Luca · 2020 · Cardiovascular Therapeutics
64. Antithrombotic therapy for stroke prevention in patients with atrial fibrillation in Japan
    Tatsuya Maruhashi, Yukihito Higashi · 2020 · Expert Opinion on Pharmacotherapy
65. Intersections and Challenges in the Management of Acute Coronary Syndrome and Stroke: Pathophysiology, Treatment Dilemmas, and Integrated Prevention Strategies
    Maria Cristina Carella, Eugenio Carulli, Francesco Loizzi, Simona Quarta, Alessandra Freda, Paolo Basile, Fabio Amati, Marco Maria Dicorato, Michele Davide Latorre, Maria Ludovica Naccarati et al. · 2025 · Journal of Clinical Medicine
66. A history of the development of dual antiplatelet therapy for coronary artery disease
    John Joseph Coughlan, Rory Durand, John P. Birrane, Ben Blackburne, Adnan Kastrati, Robert A. Byrne · 2025 · Journal of Thrombosis and Haemostasis
67. Comparative Safety of Anticoagulant, Antiplatelet and the Combination of Both for Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis
    Qingsheng Niu, Ziyi Zhu, Fulin Wang, Yaowen Jiang · 2025 · Biomedicines
68. Omission of aspirin after ACS or stenting in patients with oral anticoagulation – why have the goalposts moved?
    Robert A. Byrne, Róisín Colleran, Adnan Kastrati · 2019 · EuroIntervention
69. Interdisziplinäre Aspekte der oralen Antikoagulation mit NOAKs bei Vorhofflimmern
    Daniel Dürschmied, Andreas Goette, Roland Hardt, Christoph Kleinschnitz, Wolfgang Kämmerer, Christoph Lembens, Wilhelm H. Schmitt, Christoph Bode · 2021 · DMW - Deutsche Medizinische Wochenschrift
70. Comorbidities and Antithrombotic Treatment Pattern in Patients With Atrial Fibrillation
    Oh Young Bang, Siin Kim, Young Keun On, Myung‐Yong Lee, Sung-Won Jang, Seongwook Han, Jaeyun Ryu, Seongsik Kang, Hae Sun Suh, Young‐Hoon Kim · 2022 · Frontiers in Neurology
71. Antiplatelet Aggregation Properties of Cirsilineol: A Novel Inhibitor of Blood Coagulation Factor Xa
    Go Oun Kim, Jong Beom Heo, Dong Ho Park, Gyu‐Yong Song, Jong‐Sup Bae · 2023 · Pharmaceuticals
72. Direct Oral Anticoagulants Affect Activated Clotting Time During and Bleeding Events After Percutaneous Coronary Intervention
    Eiji Shibahashi, Takuro Abe, Kazuho Kamishima, Suguru Ebihara, Tetsu Moriyama, Kensuke Shimazaki, Kozue Saito, Yasuko Uchigata, Kentaro Jujo · 2023 · The American Journal of Cardiology
73. The Role of Direct Oral Anticoagulants in the Treatment of Cancer-Associated Venous Thromboembolism: Review by Middle East and North African Experts
    Shouki N. Bazarbashi, Heba El Zawahry, Tarek M Owaidah, Mohammad AlBader, Ashraf Warsi, Mahmoud Marashi, Emad Anwar Dawoud, Hassan Jaafar, Sherif Mohamed Sholkamy, Fadi Haddad et al. · 2024 · Journal of Blood Medicine
74. Pharmacotherapy for Coronary Artery Disease and Acute Coronary Syndrome in the Aging Population
    Errol Moras, Syed Zaid, Kruti Gandhi, Nitin Barman, Yochai Birnbaum, Salim S. Virani, Jacqueline E. Tamis‐Holland, Hani M. Jneid, Chayakrit Krittanawong · 2024 · Current Atherosclerosis Reports
75. Antiplatelet Therapy for Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Vincenzo Fioretti, Luca Sperandeo, Donato Gerardi, Aldo Di Fazio, Eugenio Stabile · 2024 · Journal of Clinical Medicine
76. Outcome measures for randomised clinical trials and multicentre observational studies of cardiovascular diseases published in major clinical journals: systematic review and evidence mapping
    Asad Bhatty, Chris Wilkinson, Suleman Aktaa, Gorav Batra, Benjamin Beska, Phyo H Khaing, Ali Wahab, Keerthenan Raveendra, Ahmed Taha, Ramesh Nadarajah et al. · 2025 · Heart
77. Direct oral anticoagulants across the heart failure spectrum: the precision medicine era
    Stefania Paolillo, Gaetano M. Ruocco, Pasquale Perrone Filardi, Alberto Palazzuoli, Carlo Gabriele Tocchetti, Savina Nodari, Carlo Lombardi, Marco Metra, Michele Correale, on behalf of “Right and Left Heart Failure Study Group” of the Italian Society of Cardiology · 2020 · Heart Failure Reviews
78. Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants
    Andreas Goette, Pascal Vranckx · 2020 · European Heart Journal Supplements
79. Oral Factor Xa Inhibitors versus Warfarin for the Treatment of Venous Thromboembolism in Advanced Chronic Kidney Disease
    Tania Ahuja, Kelly Sessa, Cristian Merchan, John Papadopoulos, David Green · 2021 · Advances in Hematology
80. Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF)
    Lisa M. Riesinger, Claudia Strobl, David M. Leistner, Tommaso Gori, İbrahim Akın, Michael Mehr, Antonia Kellnar, Amir Abbas Mahabadi, Harilaos Bogossian, Michael S. Block et al. · 2021 · IJC Heart & Vasculature
81. Survey of clinical practice pattern in Germany’s certified chest pain units
    Frank Breuckmann, Stephan Settelmeier, Tienush Rassaf, Felix Post, Winfried Haerer, Johann K Bauersachs, Harald G. Mudra, Thomas Voigtländer, Jochen Senges, Thomas F. Münzel et al. · 2021 · Herz
82. The WOEST 2 registry
    A. J. W. M. de Veer, Naoual Bennaghmouch, Willem L. Bor, JEAN PAUL HERRMAN, Mathias Vrolix, Martijn Meuwissen, Tom R. Vandendriessche, Tom Adriaenssens, Bernard De Bruyne, Michael Magro et al. · 2022 · Netherlands Heart Journal
83. ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes
    Leonardo De Luca, Andrea Rubboli, Maddalena Lettino, Marco Tubaro U, Sergio Leonardi, Gianni Casella, Serafina Valente, Roberta Rossini, Alessandro Sciahbasi, Enrico Natale et al. · 2022 · European Heart Journal Supplements
84. Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines
    Georges Jourdi, Guillaume Marquis‐Gravel, Anne‐Céline Martin, Marie Lordkipanidzé, Anne Godiér, Pascale Gaussem · 2022 · Frontiers in Pharmacology
85. Evolution of and Evidence-Practice Gaps in Antithrombotic Management of Atrial Fibrillation Patients After Percutaneous Coronary Intervention
    Laurie‐Anne Boivin‐Proulx, Brian James Potter, Marc Dorais, Sylvie Perreault · 2022 · CJC Open
86. A network meta-analysis of the antithrombotic strategies in patients with atrial fibrillation and percutaneous coronary interventions: Focus on bleeding
    Kyriakos S. Dimitriadis, Στέργιος Σουλαϊδόπουλος, Ioannis Doundoulakis, Panagιotis Iliakis, Dimitris Tsiachris, Panagiotis Tsioufis, Eirini Beneki, Athanasios Sakalidis, Eirini Pagkalidou, Eleftherios G. Tsiamis et al. · 2023 · Hellenic Journal of Cardiology
87. Temporal Trends in Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention From 2014 to 2022 in Japan
    Yasuhiro Nakano, Tetsuya Matoba, Mitsutaka Yamamoto, Shunsuke Katsuki, Yasuaki Koga, Yasushi Mukai, Shujiro Inoue, Nobuhiro Suematsu, Taiki Higo, Masao Takemoto et al. · 2023 · Circulation Reports
88. Antithrombotic strategy in cancer patients comorbid with acute coronary syndrome and atrial fibrillation
    Tianbo Wang, Xiaohan Liu, Yuxin Zhu, Yue Zhang, Zhen Zhang, Gang H. Huang, Junbo Xu · 2023 · Frontiers in Cardiovascular Medicine
89. Double Jeopardy: Will the new trials tell us how to manage patients with atrial fibrillation and coronary artery disease?
    Reza Wakili, Lisa M. Riesinger, Anke C. Fender, Dobromir Dobrev · 2019 · IJC Heart & Vasculature
90. Prevention of Stroke in Atrial Fibrillation After Coronary Stenting
    Leonardo Knijnik, Manuel Rivera, Vanessa L. Blumer, Rhanderson N. Cardoso, Amanda Dantas Ferreira Fernandes, Gilson Costa Fernandes, Tanira Ferreira, José G. Romano, Litsa Konstance Lambrakos, Mauricio G. Cohen · 2019 · Stroke
91. Triple versus double antithrombotic therapy in patients with atrial fibrillation and stent implantation: a meta‑analysis of randomized trials
    Stefan Grajek, Anna Olasińska‐Wiśniewska, Michał Michalak, Shay S. Ritter · 2019 · Kardiologia Polska
92. Time‐trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF‐STENT Registry
    Laurie‐Anne Boivin‐Proulx, Ariane Deneault‐Marchand, Alexis Matteau, Samer Mansour, François Gobeil, A. John Camm, Keith A.A. Fox, Brian James Potter · 2019 · Clinical Cardiology
93. Direct-acting Anticoagulants in Chronic Coronary Syndromes
    Emmanuel Sorbets, Philippe Gabríel Steg · 2020 · European Cardiology Review
94. Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulants
    Alessandra Serrao, Benedetta Lucani, Giovanni Manfredi Assanto, Luciano Fiori, Erminia Baldacci, Simona Michela Aprile, Antonio Chistolini · 2020 · Journal of Thrombosis and Thrombolysis
95. Benefit of dual antithrombotic therapy with direct oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention: a systematic review and metaanalysis of randomized clinical trials
    Giacomo Zoppellaro, Giuseppe Maria Marchese, Alessandro Squizzato, Gentian Denas, Giuseppe Patti, Raffaele De Caterina, Vittorio Pengo · 2020 · Internal and Emergency Medicine
96. A Comprehensive Appraisal of Dabigatran Etexilate Clinical Evidence and Applications: A 10-year-long Story
    Giulio Francesco Romiti, Bernadette Corica, Marco Proietti · 2020 · Future Cardiology
97. Effects of antithrombotic drugs on the prothrombotic state in patients with atrial fibrillation: The west Birmingham atrial fibrillation project
    Christos Voukalis, Gregory Y.H. Lip, Eduard Shantsila · 2021 · Thrombosis Research
98. Antiplatelet therapy in percutaneous coronary intervention: latest evidence from randomized controlled trials
    Mattía Galli, Dominick Joseph Angiolillo · 2021 · Current Opinion in Cardiology
99. Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
    Shujuan Zhao, Xuejiao Hong, Haixia Cai, Mingzhou Liu, Bing Li, Peizhi Ma · 2021 · Frontiers in Cardiovascular Medicine
100. Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation
     Hidehira Fukaya, Junya Ako, Satoshi Yasuda, Koichi Kaikita, Masaharu Akao, Tetsuya Matoba, Masato Nakamra, Katsumi Miyauchi, Nobuhisa Hagiwara, Kazuo Kimura et al. · 2021 · Heart